Startseite>>Signaling Pathways>> Ubiquitination/ Proteasome>> Mitophagy>>PARL-IN-1

PARL-IN-1

Katalog-Nr.GC71203

PARL-IN-1 ist ein starker PARL-Inhibitor mit einem IC50-Wert von 28 nM.

Products are for research use only. Not for human use. We do not sell to patients.

PARL-IN-1 Chemische Struktur

Größe Preis Lagerbestand Menge
1 mg
342,00 $
Auf Lager
5 mg
855,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
PARL-IN-1 is a potent PARL inhibitor with an IC50 value of 28 nM. PARL-IN-1 inhibits PARL and leads to a robust activation of the PINK1/Parkin pathway. PARL-IN-1 promotes PINK1/Parkin-dependent mitophagy.

PARL-IN-1 (compound 5; 5 nM-20 μM) impedes mitochondrial stress-induced cleavage of PGAM by PARL in cells and inhibits the cleavage of overexpressed human PGAM5 in HEK293T cells in a dose-dependent manner[1].
PARL-IN-1 (0.1-30 μM; 8 h; HEK293T cells) stabilizes PINK1 and triggers its alternative cleavage and trafficking in living cells[1].
PARL-IN-1 (5 μM; 22 h; HEK293 T-REx cells) blocks the respiratory chain leading to aberrant reactive oxygen species (ROS) production, activates the PINK1/Parkin pathway[1].

References:
[1]. Poláchová E, et, al. Chemical Blockage of the Mitochondrial Rhomboid Protease PARL by Novel Ketoamide Inhibitors Reveals Its Role in PINK1/Parkin-Dependent Mitophagy. J Med Chem. 2023 Jan 12;66(1):251-265.

Bewertungen

Review for PARL-IN-1

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PARL-IN-1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.